These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 15270716

  • 1. Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers.
    Ross MF, Filipovska A, Smith RA, Gait MJ, Murphy MP.
    Biochem J; 2004 Nov 01; 383(Pt. 3):457-68. PubMed ID: 15270716
    [Abstract] [Full Text] [Related]

  • 2. Cell-penetrating peptides are excluded from the mitochondrial matrix.
    Ross MF, Murphy MP.
    Biochem Soc Trans; 2004 Dec 01; 32(Pt 6):1072-4. PubMed ID: 15506968
    [Abstract] [Full Text] [Related]

  • 3. Alternative mechanisms for the interaction of the cell-penetrating peptides penetratin and the TAT peptide with lipid bilayers.
    Yesylevskyy S, Marrink SJ, Mark AE.
    Biophys J; 2009 Jul 08; 97(1):40-9. PubMed ID: 19580742
    [Abstract] [Full Text] [Related]

  • 4. Membrane binding and translocation of cell-penetrating peptides.
    Thorén PE, Persson D, Esbjörner EK, Goksör M, Lincoln P, Nordén B.
    Biochemistry; 2004 Mar 30; 43(12):3471-89. PubMed ID: 15035618
    [Abstract] [Full Text] [Related]

  • 5. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain.
    Koppelhus U, Shiraishi T, Zachar V, Pankratova S, Nielsen PE.
    Bioconjug Chem; 2008 Aug 30; 19(8):1526-34. PubMed ID: 18646838
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
    Turner JJ, Arzumanov AA, Gait MJ.
    Nucleic Acids Res; 2005 Aug 30; 33(1):27-42. PubMed ID: 15640444
    [Abstract] [Full Text] [Related]

  • 7. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
    Meloni BP, Craig AJ, Milech N, Hopkins RM, Watt PM, Knuckey NW.
    Cell Mol Neurobiol; 2014 Mar 30; 34(2):173-81. PubMed ID: 24213248
    [Abstract] [Full Text] [Related]

  • 8. Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide.
    Zhang X, Jin Y, Plummer MR, Pooyan S, Gunaseelan S, Sinko PJ.
    Mol Pharm; 2009 Mar 30; 6(3):836-48. PubMed ID: 19278221
    [Abstract] [Full Text] [Related]

  • 9. Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease.
    Muratovska A, Lightowlers RN, Taylor RW, Turnbull DM, Smith RA, Wilce JA, Martin SW, Murphy MP.
    Nucleic Acids Res; 2001 May 01; 29(9):1852-63. PubMed ID: 11328868
    [Abstract] [Full Text] [Related]

  • 10. Accumulation of lipophilic dications by mitochondria and cells.
    Ross MF, Da Ros T, Blaikie FH, Prime TA, Porteous CM, Severina II, Skulachev VP, Kjaergaard HG, Smith RA, Murphy MP.
    Biochem J; 2006 Nov 15; 400(1):199-208. PubMed ID: 16948637
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells.
    Thorén PE, Persson D, Isakson P, Goksör M, Onfelt A, Nordén B.
    Biochem Biophys Res Commun; 2003 Jul 18; 307(1):100-7. PubMed ID: 12849987
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I, Akita H, Kogure K, Gräslund A, Langel U, Harashima H, Futaki S.
    Acc Chem Res; 2012 Jul 17; 45(7):1132-9. PubMed ID: 22208383
    [Abstract] [Full Text] [Related]

  • 18. siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.
    Al Soraj M, He L, Peynshaert K, Cousaert J, Vercauteren D, Braeckmans K, De Smedt SC, Jones AT.
    J Control Release; 2012 Jul 10; 161(1):132-41. PubMed ID: 22465675
    [Abstract] [Full Text] [Related]

  • 19. No entry for TAT(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides.
    Krämer SD, Wunderli-Allenspach H.
    Biochim Biophys Acta; 2003 Jan 31; 1609(2):161-9. PubMed ID: 12543377
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.